Parecer de pré-exame
#6.23
09/16/2025
RPI 2854
Application data
Number
112020012388Type
Filing
Publication
PCT
IB2018060507 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 09/16/2025. We update with every new RPI gazette, published weekly.
Applicants
ADIENNE S.A.
CH
Inventors
A. N. (pessoa física)
CH
IPC Classification
Priority claims
IT
102017000148959 · 12/22/2017
Abstract
A presente invenção refere-se a um método celular quantitativo para a determinação in vitro do efeito de um ligante anti-CD26, preferivelmente de um anticorpo monoclonal anti-CD26, como begelomabe.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
09/16/2025
RPI 2854
#15.35
12/07/2021
RPI 2657
#1.3
11/24/2020
RPI 2603
#1.1
10/20/2020
RPI 2598
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.